Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
Indian Pacing and Electrophysiology Journal, 2003 Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is characterized by the patchy replacement of myocardium by fatty or fibrofatty tissue.
Julia H. Indik, Frank I. Marcus
doaj +2 more sources
Catheter Ablation of Ventricular Tachycardia/Fibrillation in a Patient with Right Ventricular Amyloidosis with Initial Manifestations Mimicking Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. [PDF]
Korean Circ J, 2017 Differentiating arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) from other cardiomyopathies is clinically important but challenging.
Chung FP, Lin YJ, Kuo L, Chen SA.
europepmc +2 more sources
Arrhythmogenic right ventricular dysplasia
Revista Cubana de Cardiología y Cirugía Cardiovascular, 2011 The arrhythmogenic right ventricular dysplasia is a genetic base cardiomyopathy, characterizedby the substitution of the miocardic tissue by an adipose or a fibroadipose one.
Marleny Cruz Cardentey +1 more
doaj +1 more source
A Prenatal Case of Arrhythmogenic Right Ventricular Dysplasia [PDF]
Arquivos Brasileiros de Cardiologia, 2018 Lilian Maria Lopes +4 more
doaj +2 more sources
Arrhythmogenic right ventricular dysplasia [PDF]
Current Treatment Options in Cardiovascular Medicine, 1999 Despite recurrences of ventricular tachycardia, patients with arrhythmogenic right ventricular dysplasia have a favorable prognosis with medical therapy. Because of the low incidence of arrhythmic death and the problems involved in identifying patients at high risk, it is difficult to evaluate the benefits of interventional therapies (ablation, surgery,
, Trohman, , Sahu
+7 more sources
Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotype-driven study (BRAVE study). [PDF]
Clin Cardiol, 2018 Morel E +9 more
europepmc +2 more sources
From Palpitations to Prevention: Timely Recognition of Biventricular ACM Preventing Sudden Cardiac Death. [PDF]
Case Rep CardiolSudden cardiac death (SCD) is a prevalent and significant health concern which may be preceded by palpitations and presyncope in a young patient. Of the arrhythmogenic causes of SCD, arrhythmogenic cardiomyopathy (ACM) is rare but important with a high morbidity and mortality.
Singh J, Adel FW, Chen HH.
europepmc +2 more sources
Orphanet Journal of Rare Diseases, 2022 Background Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is associated with ventricular arrhythmia, heart failure (HF), and sudden death. Thromboembolism is also an important and serious complication of ARVC/D.
Jia Chen +9 more
semanticscholar +1 more source
Arrhythmogenic right ventricular dysplasia [PDF]
Australian and New Zealand Journal of Medicine, 1991 Abstract A 23‐year‐old man presented with recurrent exercise‐induced ventricular tachycardia (VT), complicated by systemic embolisation. Catecholamine ‐ sensitive VT was reproduced on exercise testing and programmed electrical stimulation, displaying features suggestive of enhanced automaticity as well as re‐entry.
D, Fatkin +3 more
openaire +2 more sources
Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy [PDF]
Circulation, 2003 Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a disease characterized by fatty replacement of the right ventricular muscle (1). The residual myocardial fibers are often embedded in fibrous tissue. This substrate is conducive to right ventricular re-entrant arrhythmias. Initially this condition was called dysplasia because it was
Kathleen, Gear, Frank, Marcus
openaire +2 more sources